RJF:NYSERaymond James Financial, Inc. Analysis

RJF trades at $151.46, below its 20‑day SMA of $154.53 and well under the 200‑day SMA of $160.20, indicating short‑term weakness. RSI 46.5 and a bearish MACD histogram reinforce a neutral‑to‑bearish technical outlook, with support near $147.32 and resistance around $161.08. Despite the technical softness, the stock’s trailing P/E of 14.3 is notably lower than the industry average of 16.8, and the forward P/E of 11.3 suggests earnings acceleration. Revenue grew 13% YoY to $14.7 bn and forward EPS is projected at $13.38, reflecting solid top‑line momentum. The dividend yield of 1.43% with a payout ratio under 20% points to a sustainable income stream. Cash on hand ($17.1 bn) exceeds total debt ($6.1 bn), yielding a comfortable debt‑to‑equity of 48.5%.
The DCF model places fair value near $264, implying upside of over 15% versus the current price, while analyst consensus remains a “buy” with a median target of $172. Low beta (~1.0) and stable trading volume mitigate liquidity concerns, though 30‑day volatility of ~24% signals price swings. Combined with strong ROE (17%) and a modest dividend, the fundamentals tilt the stock toward being undervalued and a blend of growth and value. Given the extreme greed sentiment in the market, RJF appears positioned for a rebound as earnings and cash generation continue. Investors should consider adding exposure while monitoring the near‑term technical support level.